Magna International Inc: Form 40-F for the period ended Dec 31, 2023
Filed with the SEC on Mar 28, 2024 and accepted by EDGAR at Mar 28, 2024, 16:19 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $42.80bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $37.19bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months2023-01-01 to 2023-12-31 | $862.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2023-01-01 to 2023-12-31 | $2.05bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 12 months2023-01-01 to 2023-12-31 | $242.0m | us-gaap:InterestExpense |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $320.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-31 | $1.21bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | $4.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | $4.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 286,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $3.15bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $2.50bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2023-01-01 to 2023-12-31 | $522.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2023-01-01 to 2023-12-31 | $13.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $1.20bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $14.04bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $32.26bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $13.23bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $19.98bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $4.17bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $819.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-12-31 | $511.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-12-31 | $11.88bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-12-31 | 286,554,574 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-24-080656. Last ingested by Listed: Oct 30, 2026, 15:54 ET. Listed shows no prices and gives no investment advice.